NADJA SCHWARZ advises on all aspects of German business and corporate law, with a particular focus on life sciences and domestic and cross-border mergers and acquisitions. Her practice combines EU and German regulatory, compliance, and private equity/M&A knowledge. Nadja’s clients include domestic and international private equity funds, asset managers, strategic investors, pharmaceutical, biotechnology, medical device, food, cosmetic, and other consumer goods companies.
During her studies and legal clerkship, Nadja received legal training in Germany and the U.S.